Preliminary Results Presentation for the year ended 31 March 2020
To view the presentation of the preliminary results for the year ended 31 March 2020 please click here.
A recording of the webcast can be accessed via the following link:
Association for research in vision and ophthalmology (ARVO) annual meeting 2019 : Jason Commander presentation
Proactive Investors ‘ReNeuron provides encouraging update to phase II eye disease trial’
OIS: Ophthalmology Innovation & Investment – ReNeuron using hRPCs to treat inherited retinal degenerative diseases
ReNeuron signs retinal stem cell exclusivity agreement
CEO Presents at Cell & Gene Investor Day, April 2017, Boston
CFO Michael Hunt Presents at Shares Magazine Investor Evening – 27th October 2016
CEO Presents at the 6th Annual Cell & Gene Partnering Forum on the Mesa 2016
KOL Event June 2016 – Retinitis Pigmentosa
To view the webcast of the KOL Event on Degenerative Eye Disease – Retinitis Pigmentosa which was held IN nEW York on the 13th June 2016 click here..
CEO Presents at Cell & Gene Therapy Investor Day March 2016